統合失調症は、幻覚や妄想、思考や行動の乱れ、乱れた言動、思考障害、意欲の欠如など、さまざまな症状を引き起こし、日常生活に支障をきたすようになります。統合失調症の有病率の上昇やメンタルヘルスに対する意識の高まり、また、大手企業による戦略的な取り組みが、世界市場の需要を加速させている要因となっています。例えば、世界保健機関（WHO）の推計によると、2022年現在、統合失調症は世界で約2,400万人、300人に1人（0.32％）が罹患していると言われています。成人では222人に1人（0.45％）です。さらに、市場は、最近の製品の承認、およびパートナーシップを含む主要な市場プレーヤーからのいくつかの戦略的イニシアチブを目撃し、世界統合失調症薬市場の成長に影響を与えると思われます。例えば、2021年9月、ジョンソン・エンド・ジョンソン（Johnson & Johnson）社は、長時間作用型非定型抗精神病薬INVEGA HAFYERA（パルミチン酸パリペリドン6ヶ月）の薬剤について米国食品医薬品局（FDA）の承認を取得しました。この新薬は、年2回の注射剤で、成人の統合失調症の治療を目的としています。さらに、2021年11月には、イギリスのロンドンに拠点を置くSosei Heptares社とアメリカのカリフォルニア州サンディエゴに拠点を置くNeurocrine Biosciences社が、統合失調症およびその他の神経精神疾患に対する新規ムスカリン受容体アゴニストの開発に関する提携を締結しています。また、老年人口の増加や不安・うつ病の増加も、予測期間中の市場需要を喚起する要因になると予想されます。しかし、統合失調症に対する認識不足や統合失調症治療薬に関連する中毒の増加などが、2022年から2028年の予測期間における市場の成長を阻害しています。
統合失調症治療薬の世界市場調査において考慮された主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の世界地域が含まれます。北アメリカは、精神障害の発生件数の増加や大手企業の存在により、市場シェアの面で世界の主要地域となっています。一方、アジア太平洋地域は、予測期間の2022年から2028年にかけて著しい成長率を示すと予想されています。ヘルスケア産業の活発な成長や老年人口の増加などの要因は、アジア太平洋地域における世界の統合失調症治療薬市場に有利な成長の見通しを生み出すでしょう。
この調査の目的は、近年の様々なセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Schizophrenia Drugs Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Schizophrenia Drugs Market, by Therapeutic Class, 2020-2028 (USD Million)
1.2.3. Global Schizophrenia Drugs Market, by Treatment, 2020-2028 (USD Million)
1.2.4. Global Schizophrenia Drugs Market, by Distribution Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Schizophrenia Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Schizophrenia Drugs Market Dynamics
3.1. Schizophrenia Drugs Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of Schizophrenia
3.1.1.2. Increasing awareness towards mental health.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. Lack of awareness towards Schizophrenia.
3.1.2.2. Increasing incidences of addiction associated with Schizophrenia drugs
3.1.3. Market Opportunities
3.1.3.1. Growing number of geriatric individuals.
3.1.3.2. Increasing incidences of anxiety and depression.
Chapter 4. Global Schizophrenia Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Schizophrenia Drugs Market, by Therapeutic Class
6.1. Market Snapshot
6.2. Global Schizophrenia Drugs Market by Therapeutic Class, Performance - Potential Analysis
6.3. Global Schizophrenia Drugs Market Estimates & Forecasts by Therapeutic Class 2018-2028 (USD Million)
6.4. Schizophrenia Drugs Market, Sub Segment Analysis
6.4.1. Second Generation
6.4.2. Third Generation
Chapter 7. Global Schizophrenia Drugs Market, by Treatment
7.1. Market Snapshot
7.2. Global Schizophrenia Drugs Market by Treatment, Performance - Potential Analysis
7.3. Global Schizophrenia Drugs Market Estimates & Forecasts by Treatment 2018-2028 (USD Million)
7.4. Schizophrenia Drugs Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Injectable
Chapter 8. Global Schizophrenia Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Schizophrenia Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Schizophrenia Drugs Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
8.4. Schizophrenia Drugs Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
Chapter 9. Global Schizophrenia Drugs Market, Regional Analysis
9.1. Schizophrenia Drugs Market, Regional Market Snapshot
9.2. North America Schizophrenia Drugs Market
9.2.1. U.S. Schizophrenia Drugs Market
9.2.1.1. Therapeutic Class estimates & forecasts, 2018-2028
9.2.1.2. Treatment estimates & forecasts, 2018-2028
9.2.1.3. Distribution Channel estimates & forecasts, 2018-2028
9.2.2. Canada Schizophrenia Drugs Market
9.3. Europe Schizophrenia Drugs Market Snapshot
9.3.1. U.K. Schizophrenia Drugs Market
9.3.2. Germany Schizophrenia Drugs Market
9.3.3. France Schizophrenia Drugs Market
9.3.4. Spain Schizophrenia Drugs Market
9.3.5. Italy Schizophrenia Drugs Market
9.3.6. Rest of Europe Schizophrenia Drugs Market
9.4. Asia-Pacific Schizophrenia Drugs Market Snapshot
9.4.1. China Schizophrenia Drugs Market
9.4.2. India Schizophrenia Drugs Market
9.4.3. Japan Schizophrenia Drugs Market
9.4.4. Australia Schizophrenia Drugs Market
9.4.5. South Korea Schizophrenia Drugs Market
9.4.6. Rest of Asia Pacific Schizophrenia Drugs Market
9.5. Latin America Schizophrenia Drugs Market Snapshot
9.5.1. Brazil Schizophrenia Drugs Market
9.5.2. Mexico Schizophrenia Drugs Market
9.6. Rest of The World Schizophrenia Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AbbVie
10.2.3. AstraZeneca
10.2.4. Bristol Myers Squibb
10.2.5. Eli Lilly
10.2.6. GlaxoSmithKline
10.2.7. Johnson & Johnson
10.2.8. Merck KGAA
10.2.9. Minerva Neurosciences
10.2.10. Novartis AG
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Schizophrenia Drugs Market, report scope
TABLE 2. Global Schizophrenia Drugs Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Schizophrenia Drugs Market estimates & forecasts by Therapeutic Class 2018-2028 (USD Million)
TABLE 4. Global Schizophrenia Drugs Market estimates & forecasts by Treatment 2018-2028 (USD Million)
TABLE 5. Global Schizophrenia Drugs Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
TABLE 6. Global Schizophrenia Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Schizophrenia Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Schizophrenia Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Schizophrenia Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Schizophrenia Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Schizophrenia Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Schizophrenia Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Schizophrenia Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Schizophrenia Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Schizophrenia Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. U.S. Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 20. Canada Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 23. UK Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 26. Germany Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 29. RoE Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 32. China Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 35. India Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 38. Japan Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 41. RoAPAC Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 44. Brazil Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 47. Mexico Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 50. RoLA Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Schizophrenia Drugs Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 53. Row Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Schizophrenia Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Schizophrenia Drugs Market
TABLE 56. List of primary sources, used in the study of global Schizophrenia Drugs Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Schizophrenia Drugs Market, research methodology
FIG 2. Global Schizophrenia Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Schizophrenia Drugs Market, key trends 2021
FIG 5. Global Schizophrenia Drugs Market, growth prospects 2022-2028
FIG 6. Global Schizophrenia Drugs Market, porters 5 force model
FIG 7. Global Schizophrenia Drugs Market, pest analysis
FIG 8. Global Schizophrenia Drugs Market, value chain analysis
FIG 9. Global Schizophrenia Drugs Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Schizophrenia Drugs Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Schizophrenia Drugs Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Schizophrenia Drugs Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Schizophrenia Drugs Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Schizophrenia Drugs Market, regional snapshot 2018 & 2028
FIG 15. North America Schizophrenia Drugs Market 2018 & 2028 (USD Million)
FIG 16. Europe Schizophrenia Drugs Market 2018 & 2028 (USD Million)
FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
FIG 18. Latin America Schizophrenia Drugs Market 2018 & 2028 (USD Million)
FIG 19. Global Schizophrenia Drugs Market, company Market share analysis (2021)
